NCT04811053

HR021618 in Moderate to Severe Pain After Abdominal Surgery

A Phase Ⅱ, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HR021618 in the Treatment of Moderate to Severe Pain After Abdominal Surgery

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The study is being conducted to evaluate the efficacy and safety of HR021618 in the treatment of moderate to severe pain after abdominal surgery.

Conditions

• Pain After Abdominal Surgery

Interventions

Type	Name	Description
DRUG	HR021618	Treatment group A: HR021618 injection
DRUG	Placebo	Treatment group B: Saline injection

Timeline

• Start date: 2021-04-12
• Primary completion: 2021-07-15
• Completion: 2021-07-15
• First posted: 2021-03-23
• Last updated: 2025-05-15

Locations

1 site across 1 country: China